维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="HOLLINGSHEAD M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Synthesis of New Indeno iso- quinolines: Cytotoxic Non-Camptothecin Topoi- somerase I Inhibitors 显示文摘	JAYARAMAN M FOX B M HOLLINGSHEAD M etal	2010	J Med Chem2010，43，4：	1
2	Idarubicin显示文摘	Hollingshead L M Faulds D	1991	Drugs1991，42，：	1
3	Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase I inhibitors显示文摘	Nagarajan M Morrell A Antony S Kohlhagen G Agama K Pommier Y Ragazzon P.A Garbett N.C Chaires J.B Hollingshead M Cushman M		0，，17：	1
4	Tran- scatheter thrombolytie therapy for acute mesenteric and portal vein thrombosis 显示文摘	Hollingshead M Burke C T Mauro M A	2005	J Vasc Interv Radiol2005，16，5：	1
5	HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model 显示文摘	Taggart B R Harrington P Hollingshead M	2004	Antiviral Res2004，63，7：	1
6	PspA protects streptococcus pneumonaie from killing by apolactoferrin and antibody to PspA enhances killing of pneumococci by apolactoferrin显示文摘	Shaper M Hollingshead SK Benjamin WH	2004	Infet Immun2004，72，9：	1
7	HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model显示文摘	Taggart BR Panla Harringtona P Hollingshead M	2004	Antiviral Res2004，63，1：	1
8	Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers 显示文摘	Melin M M Hollingshead S K Briles D E	2008	Clin Vaccine Immunol2008，15，10：	1
9	Increased an-titumor activity of bevacizumab in combination with hypoxia induc-ible factor-1 inhibition显示文摘	Rapisarda A Hollingshead M Uranchimeg B	2009	Mol Cancer Ther2009，8，7：	1
10	In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethy- lamino-17-demethoxygeldanamycin hydrochloride), a water- soluble geldanamycin derivative 显示文摘	Hollingshead M Alley M Burger AM	2005	Cancer Chemother Pharmacol2005，56，2：	1
11	Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis显示文摘	Hollingshead M Burke CT Mauro MA		0，，05：	1
12	Synthesis of new dihydroindeno isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model显示文摘	JAYARAMAN M FOX BM HOLLINGSHEAD M	2002	J Med Chem2002，45，1：	1
13	Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKBl-mutant non small cell lung cancer cells 显示文摘	Memmott R M Gills J J Hollingshead M	2008	Cancer Res2008，68，2：	1
14	Schedule- dependent inhibition of hypoxia-inducible factor-1 alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts 显示文摘	Rapisarda A Zalek J Hollingshead M	2004	Cancer Res2004，64，：	1
15	Transcatheter thrombolytic for acute mesenteric and portal vein thrombosis 显示文摘	Hollingshead M Burke CT Mauro MA	2005	J Vasc Interv Radiol2005，16，5：	1
16	HIV hol- low fiber SCID model for antiviral therapy comparison with SCID/hu model显示文摘	TAGGART B R HARRINGTON P HOLLINGSHEAD M	2004	Antiviral Res2004，63，7：	1
17	Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis显示文摘	Hollingshead M Burke CT Mauro MA	2005	J Vasc lnterv Radiol2005，16，5：	1
18	Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition显示文摘	Rapisarda A Hollingshead M Uranchimeg B		0，，07：	1
19	Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues,novel lipid based inhibitors of Akt显示文摘	Gills JJ Holbeck S Hollingshead M		0，，03：	1
20	Preclinical modeling of a phase 0 clinical trial:qualification of a pharmacodynamic assay ofpoly (ADP-ribose) polymerase in tumor biopsies of mouse xenografts显示文摘	Kinders R J Hollingshead M Khin S		0，，21：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示